They are primarily being used to package and deliver the current generation of cancer
cell killing drugs and progress is being made in that effort.
Not exact matches
Unlike chemotherapy, which involves administering powerful
drugs that
kill both cancerous and healthy
cells (most healthy
cells can repair themselves), immunotherapies harness the power of the immune system to help it identify and knock out just the cancerous
cells.
The experimental
drug, according to reports, sharply reduced the
cell -
killing protein in the subjects» nervous systems and apparently had no major side effects.
Pagan said that a larger, more comprehensive study must be done before determining the
drug's true impact, but if the
drug's effectiveness is confirmed in such tests, nilotinib could become the first treatment to impede the
killing of brain
cells that's consistent with Parkinson's, according to NPR.
Its
drug Niraparib
kills cancer
cells by inhibiting the production of proteins called PARPs, which help repair damaged DNA strands, thereby hastening the death of some types of cancer
cells.
Her doctor suggested Erbitux — a proven cancer
drug that targets cancer
cells exclusively, unlike conventional chemotherapies that more crudely
kill all fast - growing
cells in the body — and Aucoin went to a clinic to begin treatment.
He is mystified by
cell phones and the gentrification of the neighborhood where he fell into
drugs and
killed a man.
A number of medications should be avoided while breastfeeding, including
drugs prescribed to kill cancer cells, radioactive drugs and illicit drugs, according to the American Academy of Pediatrics» Committee on D
drugs prescribed to
kill cancer
cells, radioactive
drugs and illicit drugs, according to the American Academy of Pediatrics» Committee on D
drugs and illicit
drugs, according to the American Academy of Pediatrics» Committee on D
drugs, according to the American Academy of Pediatrics» Committee on
DrugsDrugs.
Cyclophosphamide, Doxorubicin, and most chemotherapy
drugs for cancer — these
drugs kill cells in the mother's body and may harm the baby.
Most Chemotherapy
Drugs for Cancer: Since they
kill cells in the mother's body, they may harm the baby as well.
Disney said the precise binding of Targapremir - 18a to microRNA - 18a means a cancer
drug that follows this strategy would be likely to
kill prostate cancer
cells without causing the broader side effects seen with many other cancer therapies.
But that gives scientists a secret weapon — if they can harness stem
cells» natural ability to «home» toward tumor
cells, the stem
cells could be manipulated to deliver cancer -
killing drugs precisely where they are needed.
The U.S. Food and
Drug Administration approved two personalized treatments that engineer a patient's own immune system to hunt down and
kill cancer
cells.
«Once this novel tumor - homing agent binds to the EphA2 receptor, the oncogene functions as a cancer - specific molecular Trojan horse for paclitaxel, carrying the
drug inside the cancel
cell,
killing the
cell, and thwarting metastasis,» said Maurizio Pellecchia, a professor of biomedical sciences at UCR's School of Medicine who led the research.
Similarly, it may be possible to identify and validate new targets for
drugs that would selectively
kill tumor
cells with a particular molecular context.
As a result, the
drugs usually only inhibit the growth of precancerous
cells, rather than
killing them off.
But placing these «resistant»
cells temporarily in a
drug - free environment was enough to reverse the resistance: «offspring» of these
cells were once again
killed by the
drugs.
A pre-clinical study of two
drugs designed to boost T
cell performance, has revealed the agents, when give in combination, may enhance the immune system's ability to
kill melanoma tumors deficient in the tumor suppressor gene PTEN.
When Gupta's team added salinomycin to cultured human breast - cancer
cells, it was about 100 times as effective at
killing the cancer stem
cells as popular anti-cancer
drug, paclitaxel.
Chemotherapy
drugs designed to
kill tumors may actually encourage ovarian cancer by stimulating the growth of
cells that give rise to the malignancy, a new study finds.
Traditional genetic approaches together with the new wealth of genomic information for both human and model organisms open up strategies by which
drugs can be profiled for their ability to selectively
kill cells in a molecular context that matches those found in tumors.
«The concentration of the
drug stays higher in the space where the cancer is,
killing more cancer
cells.
The Cent - 1 molecule
kills cancer
cells through a mechanism similar to that of the template
drug Rigosertib that is currently under commercial development.
An experimental
drug in early development for aggressive brain tumors can cross the blood - brain tumor barrier,
kill tumor
cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James).
University of Melbourne Professor, Leann Tilley, an Australian Research Council Laureate Fellow at the Bio21 Institute, tested the new
drug in red blood
cells infected with parasites and found that it was as effective at
killing the artemisinin resistant parasites as it was for the sensitive parasites.
The researchers also used their ultrasound technique in mice to image Salmonella bacteria, which could be used to deliver cancer -
killing drugs to tumor
cells.
Chemotherapy
drugs are often designed to
kill off malignant
cells by damaging their DNA until they transition to a programmed death mode called apoptosis.
The researchers observed that two
drugs each
killed a large fraction of the
cells that had begun transitioning: dasatinib, a
drug that targets the Src Family Kinase (SFK) and RK20449, a new
drug in pre-clinical testing that specifically targets one of the SFK proteins called Hck.
The idea is to use the understanding of the pathways that adiponectin uses to
kill myeloma
cells to create a
drug that would do the same thing.
The team found that if they raised glutathione levels in cancer
cells in the lab, they reversed resistance to the
drug erlotinib, and the treatment was once again able to
kill cancer
cells.
These modifications contribute to a tumor's ability to grow indefinitely, as well as making tumor
cells drug resistant and capable of surviving treatments intended to
kill them.
Studies in cancer patients indicate reduced rates of relapse when patients are pretreated with epigenetic
drugs due to its far - reaching capabilities;
killing progenitor
cells at the site of the tumor, in circulation, or at a distant site.
Maria Zajac - Kaye, Ph.D., an associate professor in the College of Medicine's department of anatomy and
cell biology, and Rony François, an M.D. / Ph.D. student who works with her, found a new
drug combination that inhibits one form of pancreatic cancer tumor and
kills its
cells.
Mutations transform the genome of a tumor; its
cells become genetic outlaws that spread, ignore normal stop - and - go signals and evade cancer -
killing drugs or radiation.
Patients received a tandem of lenalidomide, a
drug that
kills tumor
cells, blocks blood vessel growth, and acts on the immune system, and dexamethasone, an anti-inflammatory agent, plus one of three new agents:
One form of pancreatic cancer has a new enemy: a two -
drug combination discovered by UF Health researchers that inhibits tumors and
kills cancer
cells in mouse models.
Hence, a major goal of cancer scientists has been to develop
drugs that prevent Mdm2 from binding to p53, and to thereby activate p53 to
kill the tumor
cell.
Chemotherapy
drugs kill cancer
cells, but they also affect the vasculature inside the tumor.
While the individual effects of the
drugs on virus - specific CTL differ somewhat depending on specific assays, schedules, and doses, treatment with any of the three HDAC inhibitors impaired the ability of CTL to
kill HIV - infected immune
cells.
The JDF Center for Islet
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that kills islet cells; finding new sources for islet cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
Cell Transplantation will fund 32 researchers to focus on four main goals: Reversing the overactive immune response that
kills islet
cells; finding new sources for islet
cell transplants, such as pigs or genetically engineered cells; persuading the body to accept the transplanted cells without immunosuppressive drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantat
cell transplants, such as pigs or genetically engineered
cells; persuading the body to accept the transplanted
cells without immunosuppressive
drugs that often trigger worse side effects than the disease; and overcoming the technical difficulties of transplantation.
The
drugs killed cancer
cells and also enhanced the effectiveness of chemotherapy.
Drugs that enhance a process called oxidative stress were found to
kill rhabdomyosarcoma tumor
cells growing in the laboratory and possibly bolstered the effectiveness of chemotherapy against this aggressive tumor of muscle and other soft tissue.
Though chemotherapy might
kill most of the cancer, tiny populations of
drug - resistant cancer
cells manage to survive and propagate.
Qingdong Zheng, a materials scientist at John Hopkins University in Baltimore, Maryland, suggests that such biolasers could find uses in new types of sensors or in light - based therapeutics, in which light is used, for example, to
kill cancer
cells by triggering
drugs into action that have already been administered.
It's a mixture of rituximab (which helps immune system keep cancer
cells from growing) and several chemotherapy
drugs (cyclophosphamide, doxorubicin, vincristine, and prednisone) that
kill the cancer
cells themselves.
Most researchers assumed that this is because a few rogue cancer
cells find ways to circumvent the
drugs before the whole tumour has been
killed off.
«You do
kill a few normal
cells with the
drugs, but you do that anyway with surgery,» she says.
«Our test should make it possible to find
drug combinations that
kill ALL the cancerous
cells in a tumor,» Skala said.
If a given
drug cocktail
kills 90 percent of the cancer
cells but doesn't affect the remaining 10 percent, the resistant tumor
cells can take over and cause the tumor to grow back.
The study found that combining the two
drugs had an increased effect of
killing of cancer
cells, while individually, the
drugs have considerably less impact on
cell viability.